374148167	374148167	CD	B-NP	O
|	|	NN	I-NP	O
MSH	MSH	NN	I-NP	O
|	|	NN	I-NP	O
94481519	94481519	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4472254	4472254	CD	B-NP	O
|	|	CC	I-NP	O
3/28/2006	3/28/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HTN	HTN	NNP	I-NP	I-protein
EMERGENCY	EMERGENCY	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/23/2006	7/23/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/2/2006	8/2/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
WARNECKE	WARNECKE	NNP	B-NP	O
,	,	,	O	O
BLAIR	BLAIR	NNP	B-NP	O
E.	E.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Kata	Kata	NNP	B-NP	O
O	O	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Pneumonia	Pneumonia	NNP	B-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
OTHER	OTHER	NNP	B-NP	O
PROBLEMS/DIAGNOSES	PROBLEMS/DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Altered	Alter	VBN	B-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
,	,	,	O	O
hypertensive	hypertensive	JJ	B-NP	O
emergency	emergency	NN	I-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
hepatitis	hepatitis	NN	B-NP	O
C.	C.	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
53-year-old	53-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
polysubstance	polysubstance	NN	B-NP	O
abuse	abuse	NN	I-NP	O
and	and	CC	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
C	C	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
2/18/06	2/18/06	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
lethargic	lethargic	JJ	B-ADJP	O
after	after	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
headache	headache	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
202/91	202/91	CD	B-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-NP	O
ST	ST	JJ	I-NP	O
depression	depression	NN	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
paste	paste	NN	I-NP	O
,	,	,	O	O
labetolol	labetolol	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
headache	headache	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
decrease	decrease	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
160s	160	NNS	I-NP	B-DNA
.	.	.	O	O

On	On	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
lethargic	lethargic	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
A	A	NN	I-NP	O
Hospital	Hospital	NN	I-NP	O
with	with	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
C.	C.	FW	B-NP	O
difficile	difficile	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
completing	complete	VBG	I-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
Levaquin	Levaquin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
records	record	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
160-180	160-180	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
hypertension	hypertension	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
200s	200s	CD	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
poorly-controlled	poorly-controlled	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
and	and	CC	O	O
C	C	NN	B-NP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
,	,	,	O	O
possible	possible	JJ	B-NP	O
ethanol-related	ethanol-related	JJ	I-NP	O
liver	liver	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
peptic	peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
toe	toe	NN	B-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
recently	recently	RB	B-ADVP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
living	live	VBG	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
separated	separate	VBN	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
and	and	CC	I-NP	O
children	child	NNS	I-NP	O
who	who	WP	B-NP	O
live	live	VBP	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
state	state	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
smoker	smoker	NN	I-NP	O
and	and	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
abuser	abuser	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
heroin	heroin	NN	B-NP	O
use	use	NN	I-NP	O
and	and	CC	O	O
cocaine	cocaine	NN	B-NP	O
use	use	NN	I-NP	O
but	but	CC	O	O
currently	currently	RB	B-VP	O
not	not	RB	I-VP	O
abusing	abuse	VBG	I-VP	O
either	either	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
aspirin	aspirin	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
reaction	reaction	NN	I-NP	O
being	be	VBG	B-VP	O
epistaxis	epistaxis	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
true	true	JJ	I-NP	O
allergy	allergy	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
notable	notable	JJ	B-NP	O
findings	finding	NNS	I-NP	O
were	be	VBD	B-VP	O
an	an	DT	B-NP	O
altered	altered	JJ	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
somnolent	somnolent	JJ	B-ADJP	O
and	and	CC	O	O
confused	confuse	VBD	B-VP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
other	other	JJ	B-NP	O
significant	significant	JJ	I-NP	O
physical	physical	JJ	I-NP	O
findings	finding	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
emergency	emergency	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

Labetolol	Labetolol	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
reasonably	reasonably	RB	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
empirically	empirically	RB	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
likely	likely	JJ	B-NP	O
cavitary	cavitary	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
upon	upon	IN	B-PP	O
chest	chest	NN	B-NP	O
CT.	CT.	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
clinically	clinically	RB	I-VP	O
improved	improve	VBN	I-VP	O
on	on	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
7-day	7-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
difficile	difficile	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
PPD	PPD	NN	B-NP	O
negative	negative	JJ	I-NP	O
and	and	CC	I-NP	O
induced	induce	VBN	I-NP	O
sputum	sputum	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
by	by	IN	B-PP	O
acid	acid	NN	B-NP	O
fast	fast	JJ	I-NP	O
tests	test	NNS	I-NP	O
for	for	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
tuberculosis	tuberculosis	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
lower	low	JJR	I-NP	O
quadrant	quadrant	JJ	I-NP	O
pain	pain	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
10/30	10/30	CD	B-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
involuntary	involuntary	JJ	I-NP	O
guarding	guarding	NN	I-NP	O
was	be	VBD	B-VP	O
apparently	apparently	RB	I-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdoman	NNS	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
process	process	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
without	without	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
laboratory	laboratory	NN	I-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
alkaline	alkaline	NN	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
with	with	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
Murphy	Murphy	NN	I-NP	O
sign	sign	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
cholecystitis	cholecystitis	NN	B-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
confused	confuse	VBN	I-VP	O
and	and	CC	O	O
somnolent	somnolent	JJ	B-ADJP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
altered	altered	JJ	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reportedly	reportedly	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
tonic-clonic	tonic-clonic	JJ	I-NP	O
seizure	seizure	NN	I-NP	O
in	in	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
11/12/06	11/12/06	CD	B-NP	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
thought	think	VBN	B-VP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
fluid	fluid	NN	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
shifts	shift	NNS	I-NP	O
in	in	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
both	both	CC	O	O
EEG	EEG	NN	B-NP	B-protein
and	and	CC	I-NP	O
brain	brain	NN	I-NP	O
MRI	MRI	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
and	and	CC	I-NP	O
dialysis	dialysis	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
schedule	schedule	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
brittle	brittle	JJ	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
diabetic	diabetic	JJ	I-NP	O
and	and	CC	O	O
early	early	RB	B-ADVP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
which	which	WDT	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
AMP	AMP	NN	I-NP	O
of	of	IN	B-PP	O
D50	D50	NN	B-NP	B-protein
.	.	.	O	O

the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
which	which	WDT	B-NP	O
his	his	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
reasonably	reasonably	RB	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
without	without	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
Lantus	Lantus	NNP	B-NP	O
4	4	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
Lantus	Lantus	NNP	B-NP	O
4	4	CD	I-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
with	with	IN	B-PP	O
NovoLog	NovoLog	NN	B-NP	B-protein
3	3	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
lunch	lunch	NN	B-NP	O
and	and	CC	I-NP	O
NovoLog	NovoLog	NN	I-NP	B-protein
2	2	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
with	with	IN	B-PP	O
dinner	dinner	NN	B-NP	O
and	and	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
NovaLog	NovaLog	NN	I-NP	O
used	use	VBN	B-VP	O
only	only	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
fingersticks	fingerstick	NNS	B-NP	O
were	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Pulmonology	Pulmonology	NNP	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
left	leave	VBN	I-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
cavitary	cavitary	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
observed	observe	VBN	B-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
malignant	malignant	JJ	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
most	most	RBS	B-NP	O
likely	likely	RB	I-NP	O
represented	represent	VBN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
in	in	IN	B-PP	O
6-8	6-8	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
if	if	IN	B-SBAR	O
this	this	DT	B-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
completely	completely	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
COPD/asthma	COPD/asthma	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
Advair	Advair	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
,	,	,	O	O
systolic	systolic	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
140-160/60	140-160/60	CD	B-NP	O
-80	-80	CD	I-NP	O
and	and	CC	O	O
saturating	saturate	VBG	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
a	a	DT	B-NP	O
7-day	7-day	JJ	I-NP	O
course	course	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
esomeprazole	esomeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
100/50	100/50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
1	1	CD	I-NP	O
puff	puff	NN	I-NP	O
in	in	IN	B-PP	O
INH	INH	NN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
3	3	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
,	,	,	O	O
NovoLog	NovoLog	NN	B-NP	O
3	3	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
with	with	IN	B-PP	O
lunch	lunch	NN	B-NP	O
,	,	,	O	O
NovoLog	NovoLog	NN	B-NP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	B-NP	O
with	with	IN	B-PP	O
dinner	dinner	NN	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
4	4	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
4	4	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
and	and	CC	O	O
NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
,	,	,	O	O
labetolol	labetolol	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
Nephrocaps	Nephrocaps	RB	B-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
XL	XL	NN	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
and	and	CC	O	O
Sevelamer	Sevelamer	NN	B-NP	O
2.4	2.4	CD	I-NP	O
g	g	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
Regarding	Regard	VBG	B-VP	O
followup	followup	NN	B-NP	O
tests	test	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
needed	need	VBN	I-VP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
schedule	schedule	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
6-8	6-8	CD	B-NP	O
weeks	week	NNS	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
malignancy	malignancy	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
regular	regular	JJ	B-NP	O
Monday	Monday	NNP	I-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
dialysis	dialysis	NN	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
complete	complete	VB	I-VP	O
the	the	DT	B-NP	O
7	7	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
prescribed	prescribe	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
complete	complete	VB	I-VP	O
the	the	DT	B-NP	O
14	14	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
skilled	skilled	JJ	B-NP	O
nursing	nursing	NN	I-NP	O
facility	facility	NN	I-NP	O
from	from	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-2042463	2-2042463	CD	B-NP	O
BFFocus	BFFocus	NN	I-NP	O
Dictated	Dictate	VBD	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
SCHAMEL	SCHAMEL	NN	B-NP	O
,	,	,	O	O
LUIS	LUIS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TABONE	TABONE	NN	B-NP	O
,	,	,	O	O
SYDNEY	SYDNEY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1817673	1817673	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/17/06	1/17/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/17/06	1/17/06	CD	B-NP	O

